Difficulty: Medium
Average Score: 62%
Practice
A 32-year-old Caucasian woman experiences chest pain with exertion. She reports having similar episodes in the past. It is determined that she is experiencing stable angina. She is given nitroglycerin to relax her vascular smooth musculature. Which best describes a step on nitroglycerin's mechanism of action?
Correct answer
B
Rationale
Nitroglycerin is a vasodilator commonly used to relieve chest pain in conditions like angina. The correct answer is B) Activation of guanylate cyclase. Nitroglycerin is a prodrug that gets converted to nitric oxide (NO) in the body. Nitric oxide activates guanylate cyclase, leading to an increase in cyclic guanosine monophosphate (cGMP) levels. This cGMP then causes relaxation of vascular smooth muscle, resulting in vasodilation and decreased cardiac workload.
Option A) Activation of adenylate cyclase is incorrect because nitroglycerin does not act through the adenylate cyclase pathway.
Option C) Inhibition of calcium channels is incorrect because nitroglycerin's mechanism does not involve direct inhibition of calcium channels.
Option D) Inhibition of cGMP phosphodiesterase is incorrect because nitroglycerin actually increases cGMP levels by activating guanylate cyclase rather than inhibiting its breakdown by phosphodiesterase.
Understanding the mechanism of action of nitroglycerin is crucial in cardiovascular pharmacology as it helps in comprehending how the drug works to alleviate symptoms of angina and its potential side effects. This knowledge is essential for healthcare professionals to make informed decisions when managing patients with cardiovascular conditions.
Option A) Activation of adenylate cyclase is incorrect because nitroglycerin does not act through the adenylate cyclase pathway.
Option C) Inhibition of calcium channels is incorrect because nitroglycerin's mechanism does not involve direct inhibition of calcium channels.
Option D) Inhibition of cGMP phosphodiesterase is incorrect because nitroglycerin actually increases cGMP levels by activating guanylate cyclase rather than inhibiting its breakdown by phosphodiesterase.
Understanding the mechanism of action of nitroglycerin is crucial in cardiovascular pharmacology as it helps in comprehending how the drug works to alleviate symptoms of angina and its potential side effects. This knowledge is essential for healthcare professionals to make informed decisions when managing patients with cardiovascular conditions.